Details for New Drug Application (NDA): 087506
✉ Email this page to a colleague
NDA 087506 describes OPCON, which is a drug marketed by Bausch And Lomb and is included in two NDAs. Additional details are available on the OPCON profile page.
The generic ingredient in OPCON is naphazoline hydrochloride; pheniramine maleate. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.
The generic ingredient in OPCON is naphazoline hydrochloride; pheniramine maleate. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.
Summary for 087506
| Tradename: | OPCON |
| Applicant: | Bausch And Lomb |
| Ingredient: | naphazoline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 087506
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.1% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
